We are live on ! Find out more
ALSV

ATP Life Science Ventures Portfolio holdings

AUM $898M
1-Year Est. Return 84.86%
This Fund
S&P 500
This Quarter Est. Return
+24.88%
1 Year Est. Return
+84.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$596M
AUM Growth
–
Cap. Flow
+$534M
Cap. Flow %
89.71%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
STOK icon
Stoke Therapeutics
STOK
+$422M
2
AKRO
Akero Therapeutics
AKRO
+$112M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STOK icon
1
Stoke Therapeutics
STOK
$1.82B
$475M 79.82%
+16,786,713
New +$422M
AKRO
2
DELISTED
Akero Therapeutics
AKRO
$120M 20.18%
+5,415,203
New +$112M

Similar funds

TNB
TCF National Bank Sioux Falls, South Dakota $883M AUM 60.21% 1-Year Est. Return
FIB
First Interstate Bancsystem Billings, Montana $841M AUM
NAM
North American Management Boston, Massachusetts $738M AUM 49.23% 1-Year Est. Return
SGMP
Spark Growth Management Partners Boston, Massachusetts $591M AUM
FBP
Flippin Bruce & Porter Lynchburg, Virginia $553M AUM 70.43% 1-Year Est. Return
PA
Paracle Advisors Mercer Island, Washington $551M AUM 50.34% 1-Year Est. Return
AAM
Anglepoint Asset Management George Town, Cayman Islands $1.28B AUM 131.9% 1-Year Est. Return
PPCM
Pillar Pacific Capital Management Pacifica, California $1.29B AUM 80.18% 1-Year Est. Return

ATP Life Science Ventures's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for ATP Life Science Ventures, which disclosed 2 positions worth $596M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Stoke Therapeutics: 16,786,713 shares worth $475M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • ATP Life Science Ventures's largest Q4 2019 buy was Stoke Therapeutics: 16,786,713 shares worth $475M.
  • ATP Life Science Ventures's ten largest holdings make up 100% of its $596M portfolio in Q4 2019.
  • ATP Life Science Ventures disclosed 2 positions in Q4 2019, its first 13F filing on record.

Based on ATP Life Science Ventures's 13F filing for Q4 2019, filed 3 Feb 2020.